Mapping brain function to discover Alzheimer's biomarkers

Individual functional brain mapping for biomarker discovery in Alzheimer's

['FUNDING_R01'] · TRUSTEES OF INDIANA UNIVERSITY · NIH-11164602

This study is looking for new ways to spot Alzheimer's disease early by using brain scans and blood tests, so that people at risk can get the help they need and join clinical trials more easily.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorTRUSTEES OF INDIANA UNIVERSITY (nih funded)
Locations1 site (BLOOMINGTON, UNITED STATES)
Trial IDNIH-11164602 on ClinicalTrials.gov

What this research studies

This research aims to develop new biomarkers for Alzheimer's disease (AD) by using functional magnetic resonance imaging (fMRI) to study brain connectivity and organization. The goal is to create non-invasive screening methods that can identify individuals at risk of cognitive decline and track those eligible for new treatments. By combining fMRI with blood tests and existing imaging techniques, the researchers hope to establish a comprehensive approach to diagnosing and monitoring AD. This could make it easier for patients to participate in clinical trials and receive timely interventions.

Who could benefit from this research

Good fit: Ideal candidates for this research include older adults who are at risk of developing Alzheimer's disease or are experiencing early cognitive decline.

Not a fit: Patients with advanced Alzheimer's disease or those who do not have any cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate identification of Alzheimer's disease, improving treatment options for patients.

How similar studies have performed: Previous research has shown promise in using fMRI for brain mapping in Alzheimer's, but this specific approach to developing biomarkers is still novel.

Where this research is happening

BLOOMINGTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.